Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorderActive, not recruitingPhase 1 / Phase 22026-04-17NCT04725994

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Idience Co., Ltd.1

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Asan Medical CenterSeoulSouth Korea131
Astera Cancer CareEast BrunswickUnited States38
Beijing Cancer HospitalBeijingChina85
Beth Israel Deaconess Medical CenterBostonUnited States462
Dana Farber Cancer InstituteBostonUnited States300
Dong-A University HospitalBusanSouth Korea42
Hematology Oncology Clinic Baton Rouge / Sarah CannonBaton RougeUnited States1
Jeonbuk National University HospitalJeonjuSouth Korea7
Korea University Anam HospitalSeoulSouth Korea94
Korea University Guro HospitalSeoulSouth Korea83
Samsung Medical CenterSeoulSouth Korea170
Seoul National University Bundang HospitalSeongnamSouth Korea42
Seoul National University HospitalSeoulSouth Korea183
Severance Hospital - Yonsei Cancer CenterSeoulSouth Korea2
Shanghai East HospitalShanghaiChina33
The Sixth Affiliated Hospital of Sun Yat-sen UniversityGuangzhouChina7
USC Norris Comp. Cancer Ctr HospitalLos AngelesUnited States1